Peer Review History
| Original SubmissionNovember 7, 2025 |
|---|
|
-->PONE-D-25-59074--> Artificial intelligence meets pediatric orthopedics: a comparative analysis of ChatGPT-4o, Gemini 2.0, and Claude 3.5 in detecting supracondylar humeral fractures PLOS One Dear Dr. Kalafat, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the ’submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Uzair Yaqoob Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE’s style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that your Data Availability Statement is currently missing the repository name and/or the DOI/accession number of each dataset OR a direct link to access each database. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 4. We note that Figure 1 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. 5. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: http://file.lookus.net/journals/tjtes/bant/v31.i10.pdf In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer’s Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Yes Reviewer #5: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously?--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: No ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: No ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: AI methods for sc fracture is just tools . This study may add something to literatiure. Au tools are tools for facilitation but in real clinical practice still doubtful and may be not that good to replace the humans . Accuracy with senior surgeon and AI in this respect my be better idea to compare In future Reviewer #2: I appreciate all authors for their nice work in the field of fracture diagnosis with AI tool. I have few concern on confidentiality of data, how they protect data from company using LLMs. second, hospital having policy to take consent of all patients those are coming to emergency department for data used in research purpose Reviewer #3: Manuscript Number: PONE-D-25-59074 Title: Artificial intelligence meets pediatric orthopedics: a comparative analysis of ChatGPT-4o, Gemini 2.0, and Claude 3.5 in detecting supracondylar humeral fractures General Assessment This study evaluates the performance of three large multimodal models (ChatGPT-4o, Gemini 2.0, and Claude 3.5) in detecting and classifying pediatric supracondylar humeral fractures. The inclusion of the latest models, particularly Gemini 2.0, is a strength and adds value to the current literature. However, there are significant concerns regarding the methodology description, image preprocessing, and the interpretation of statistical results that must be addressed. Major Issues 1. Methodological Ambiguity regarding "Training" The methods section states: "For more effective interpretation, LLMs were trained using the chapters on supracondylar fractures of humerus in orthopaedic textbooks". (1)Critique: The term "trained" is technically inaccurate for commercial LLMs accessed via standard interfaces/APIs unless fine-tuning endpoints were used. It appears the authors utilized "In-Context Learning" or "System Prompting." �2)Requirement: Please replace the term "trained" with "primed" or "provided context." Crucially, the authors must clarify: Was the context window (chat history) cleared/reset for every specific patient? If not, the models likely retained information from previous cases (context leakage), rendering the accuracy data invalid. 2. Inadequate Image Resolution The manuscript notes that "Images... were saved in PNG format with a resolution of 512x512 pixels". �1�Critique: Supracondylar fractures, specifically Gartland Type I, rely on subtle findings such as the posterior fat pad sign or minor cortical disruptions. Downscaling radiographs to 512x512 pixels results in a significant loss of high-frequency detail. Current versions of GPT-4o and Gemini 2.0 support much higher resolution inputs. �2�Requirement: The authors must justify this preprocessing step. If the study cannot be re-run with high-resolution images, this must be listed as a primary limitation, as it likely handicaps the models' performance on Type I fractures. 3. Misleading Presentation of "Ideal Accuracy" and Specificity The Abstract states: "All models performed similarly in non-fracture cases with ideal accuracy rates >91%". �1�Critique: This statement is misleading when contrasted with the results in Table 3, which show that Specificity (TN / TN + FP) is very low, ranging from 33.1% to 36.0%. �2�Requirement: The "Ideal Accuracy" metric (defined as $\ge 1$ correct response out of 3) obscures the high false-positive rate. In a binary choice, a random guess has a high probability of being correct once in three tries. The Abstract and Discussion must explicitly state that while "Ideal Accuracy" was high, the models exhibited poor Specificity, leading to a high rate of false positives in healthy children. 4. Lack of Model Specification and Temporal Relevance �1�Ambiguity of Model Variants: The manuscript generically refers to "Gemini 2.0" and "Claude 3.5". However, these model families typically consist of multiple distinct versions with varying capabilities (e.g., Gemini 2.0 Flash vs. Pro vs. Ultra). Without specifying the exact version, the study is not reproducible. �2�Rapid Obsolescence: The data collection was performed in May 2025. Given the rapid iteration cycle of LLMs (with newer generations available by early 2026), the findings presented here may already be outdated. �3�Requirement: The authors must explicitly state the exact model variants used in the Methods section. The Discussion section must acknowledge this time lag as a limitation. 5. Ambiguity in Multi-View Input Strategy The methods mention that "Two-view elbow radiographs were presented", yet the prompt described is singular: "following is the image". �1�Requirement: Please clarify how two views (AP and Lateral) were input. Were they stitched into a single collage image, or uploaded as two separate files? Minor Issues 1.Clinical Utility and PPV: Table 3 shows a Positive Predictive Value (PPV) of only 23.2% for ChatGPT-4o. The Discussion should expand on the clinical implications of this: utilizing such a tool would result in a massive number of false positives. 2.Fleiss' Kappa Interpretation: The text reports "good" consistency for ChatGPT-4o in fracture cases ($\kappa=0.69$) but "weak" consistency in non-fracture cases ($\kappa=0.15$). This discrepancy suggests the models are not reliably consistent but are biased towards detecting fractures. Please discuss this distinction. 3.Statistical Reporting: In Table 2, please report exact P-values (e.g., p=0.004) rather than inequalities (p<0.001) where possible. Reviewer #4: This study is the first to compare ChatGPT-4o, Gemini 2.0, and Claude 3.5 for pediatric supracondylar humeral fracture detection and Gartland classification, addressing a critical gap in pediatric radiology AI research. The retrospective design with 300 well-characterized patients, rigorous accuracy metrics (overall/strict/ideal), and consistency analysis via Fleiss’ Kappa are major strengths, and the conclusion linking model performance to pediatric-specific training needs is well-supported by results. However, several limitations warrant revision: 1) Single-center data restricts generalizability—external validation with diverse pediatric populations is essential. 2) No details on LLM fine-tuning protocols (e.g., textbook training scope) limit reproducibility. 3) Lack of head-to-head comparison with radiologists/emergency physicians fails to contextualize LLM performance against clinical gold standards. 4) The 512×512 PNG image resolution may compromise diagnostic detail; DICOM format analysis is recommended. Minor issues include inconsistent Kappa interpretation (κ≥0.61 labeled “very good” but results described as “good”) and a typo (ChatGPT-40 for 4o). Addressing these gaps will strengthen the study’s clinical relevance and methodological rigor, enhancing its value for guiding pediatric AI model development. Reviewer #5: Summary This study evaluates the performance of three large language models (ChatGPT-4o, Gemini 2.0, and Claude 3.5) in detecting pediatric supracondylar humeral fractures and classifying them using the modified Gartland system. The topic is timely and clinically relevant. The sample size is adequate, and the assessment of response consistency across repeated sessions is a strength. The comparative evaluation of multiple multimodal LLMs adds value to the current literature. However, several methodological clarifications and contextual comparisons are necessary before publication. Major Comments 1.The manuscript refers to the study as a “systematic review,” which is incorrect. This is a retrospective diagnostic performance study and should be described consistently as such. 2. The Methods state that the LLMs were “trained” using textbook chapters. It is unclear whether this refers to fine-tuning or structured prompting. The authors should clearly describe the exact prompts, instructions, and settings used for each model to ensure reproducibility. 3. Each case was presented three times. The manuscript should clarify: Whether the unit of analysis is case-level or session-level Which decision rule (overall/strict/ideal accuracy) was used to derive sensitivity and specificity There appears to be inconsistency between reported high “ideal accuracy” in non-fracture cases and low specificity values. This should be resolved and clearly explained. 4. The manuscript would benefit from a clearer comparison with previously published non-LLM, image-specific deep learning models (e.g., CNN-based fracture detection systems). Several prior studies using convolutional neural networks or dedicated radiographic AI models have reported substantially higher sensitivity and specificity in musculoskeletal fracture detection tasks. The Discussion should: Compare the reported performance of LLMs (e.g., sensitivity ~68% for Gemini, specificity ~33%) with previously published CNN-based models. Clarify whether LLMs are intended as general-purpose multimodal systems or substitutes for specialized radiology AI. 5. Discuss why general LLMs may underperform compared to task-specific deep learning models trained on large annotated imaging datasets. This comparison is important to position the clinical relevance of LLM-based image interpretation within the broader AI literature. 6. Classification accuracy is reported only among detected fractures. It would be more clinically meaningful to report overall correct classification (correct detection and correct type combined). 7. Including representative radiographic images (true positives, false positives, false negatives, and examples of each Gartland type) would improve transparency and allow readers to better understand model errors. All images must be fully anonymized and ethically approved for publication. 8. The current statement suggests data are available within the hospital system. This may not fully comply with PLOS ONE data policies. The authors should clarify whether anonymized derived data can be shared or provide a formal access process. Minor Comments 1. Correct typographical errors (e.g., “supracondiler,” “NVP” instead of “NPV”). 2. Clearly define how ambiguous responses (e.g., “possible fracture”) were categorized. 3. Provide 95% confidence intervals for key diagnostic metrics. 4. Ensure consistent terminology throughout the manuscript. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: Yes: Nio Reviewer #2: Yes: Irfan M Rajput, Consultant Orthopedic and Sports Surgeon at Dow university Health Sciences Karachi Reviewer #3: No Reviewer #4: Yes: Tianlun Zhang Reviewer #5: Yes: Chihiro Tanikawa ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Artificial intelligence meets pediatric orthopedics: a comparative analysis of ChatGPT-4o, Gemini 2.0, and Claude 3.5 in detecting supracondylar humeral fractures PONE-D-25-59074R1 Dear Dr. Kalafat, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Lisong Zhang Academic Editor PLOS One Additional Editor Comments (optional): Reviewer 3 AI methods for sc fracture is just tools . This study may add something to literatiure. Au tools are tools for facilitation but in real clinical practice still doubtful and may be not that good to replace the humans . Accuracy with senior surgeon and AI in this respect my be better idea to compare In future Reviewers' comments: Reviewer’s Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #3: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #3: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #3: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #3: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #3: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #3: Manuscript Number: PONE-D-25-59074R1 Title: Artificial intelligence meets pediatric orthopedics: a comparative analysis of ChatGPT-4o, Gemini 2.0, and Claude 3.5 in detecting supracondylar humeral fractures The revised manuscript and the accompanying response letter have been thoroughly reviewed. The authors have provided satisfactory and scientifically rigorous responses to all major critiques. Specifically, the methodological transparency achieved by clarifying the independent chat session protocol effectively eliminates prior concerns regarding context leakage. Furthermore, the objective reporting of specificity in the revised Abstract, alongside the explicit acknowledgment of image resolution constraints (512x512 pixels) and precise model versioning in the Discussion, significantly enhances the academic rigor and reproducibility of the paper. The manuscript now meets the necessary methodological and reporting standards. No further revisions are required. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-25-59074R1 PLOS One Dear Dr. Kalafat, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Associate Professor Lisong Zhang Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .